Ferrichrome has antitumor potential in colon cancer cells by inducing the expression of DNA damage-inducible transcript-3 (DDIT3), surpassing the efficacy of conventional anticancer drugs such as 5-FU and cisplatin [16]. Here, DDIT3 is linked to malignant colon neoplasm.